|
124 Companies |
|
161 Products |
|
161 Products |
|
116 Mechanisms of Action |
|
11 Trials |
|
2428 News |
|
| «12...3738394041424344454647...4950» |
- Trial completion: Reasons for Non-treatment of Hepatitis C in HCV Mono-infected Patients Versus HCV-HIV Co-infected Patients in a University Setting (clinicaltrials.gov) - Aug 22, 2012
P=N/A, N=300, Completed, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed
- Clinical: Probono1: Determination of Optimum Age for DXA Screening for Osteoporosis in HIV - The Probono 1 Study (clinicaltrials.gov) - Aug 19, 2012
P=N/A, N=440, Completed, Sponsor: King's College London
- ViraferonPeg (peginterferon-?-2b) / Merck (MSD)
Enrollment change: Interferon Alpha 2b Intensification in HIV-Positive Individuals on Antiretroviral Therapy (clinicaltrials.gov) - Aug 17, 2012
P1/2, N=65, Recruiting, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed N=45 --> 65
- Enrollment change: DRAG: Feasibility and Limitations of Offering Community Based Rapid HIV Testing to Men Who Have Sex With Men (MSM) (clinicaltrials.gov) - Aug 16, 2012
P=N/A, N=357, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
N=45 --> 65 N=680 --> 357
- Enrollment closed: EP48 HIV CHEST: Early Lung Cancer Diagnosis in HIV Infected Population With an Important Smoking History With Low Dose CT: a Pilot Study (clinicaltrials.gov) - Aug 16, 2012
P=N/A, N=450, Active, not recruiting, Sponsor: French National Institute for Health and Medical Research-French National Agency for Research on AIDS and Viral Hepatitis (Inserm-ANRS)
N=680 --> 357 Recruiting --> Active, not recruiting
- |||||||||| ribavirin / Generic mfg.
New P3 trial: Efficacy and Safety of Sofosbuvir Plus Ribavirin in Chronic Genotype 1, 2 and 3 Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) Co-infected Adults (clinicaltrials.gov) - Aug 15, 2012
P3, N=224, Completed, Sponsor: Gilead Sciences
- ||||| HSV vaccine (GEN-003) / Genocea, Shionogi
New P1/2 trial: Safety and Immunogenicity Study of Therapeutic HSV-2 Vaccine (clinicaltrials.gov) - Aug 15, 2012
P1/2, N=150, Active, not recruiting, Sponsor: Genocea Biosciences, Inc.
- Trial withdrawal: Botswana Study of UC-781 Vaginal Microbicide (clinicaltrials.gov) - Aug 14, 2012
P1, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
Recruiting --> Active, not recruiting Not yet recruiting --> Withdrawn
- Enrollment change: Botswana Study of UC-781 Vaginal Microbicide (clinicaltrials.gov) - Aug 14, 2012
P1, N=0, Withdrawn, Sponsor: Centers for Disease Control and Prevention
Not yet recruiting --> Withdrawn N=90 --> 0
- Enrollment change: ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader (clinicaltrials.gov) - Aug 14, 2012
P=N/A, N=27, Completed, Sponsor: Centers for Disease Control and Prevention
N=90 --> 0 N=200 --> 27
- ||| rosuvastatin / Generic mfg.
Enrollment closed: Use of Rosuvastatin in HIV-Infected Subjects to Modulate Cardiovascular Risks (clinicaltrials.gov) - Aug 14, 2012
P2, N=140, Active, not recruiting, Sponsor: University Hospitals of Cleveland
N=200 --> 27 Recruiting --> Active, not recruiting
- | Invirase (saquinavir) / Roche
Trial completion: A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Na (clinicaltrials.gov) - Aug 14, 2012
P1, N=23, Completed, Sponsor: Hoffmann-La Roche
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion: ADAPT-POL New Orleans: Adaptation of Prevention Techniques With Popular Opinion Leader (clinicaltrials.gov) - Aug 14, 2012
P=N/A, N=27, Completed, Sponsor: Centers for Disease Control and Prevention
Recruiting --> Completed Recruiting --> Completed
- New P1 trial: Ferumoxytol-enhanced Brain MRI in HIV-associated Neurocognitive Disorders (clinicaltrials.gov) - Aug 13, 2012
P1, N=4, Completed, Sponsor: University of Hawaii
- ||| lopinavir/ritonavir / Generic mfg.
Adherence: Real-life Effectiveness of the Kaletra Adherence Support Assistance (KASA) Program (clinicaltrials.gov) - Aug 8, 2012
P=N/A, N=240, Recruiting, Sponsor: AbbVie (prior sponsor, Abbott)
- Trial completion: EP 49 EVARIST: Residual Risk Assessment Of HIV Transmission (clinicaltrials.gov) - Aug 8, 2012
P=N/A, N=167, Completed, Sponsor: French National Agency for Research on AIDS and Viral Hepatitis
Recruiting --> Completed Recruiting --> Completed
- | pritelivir (AIC316) / AiCuris
New P2 trial: Safety and Efficacy Comparator Trial of a New Drug Against Genital Herpes (clinicaltrials.gov) - Aug 5, 2012
P2, N=91, Terminated, Sponsor: AiCuris GmbH & Co.KG
- Rekambys (rilpivirine LA) / J&J
Trial completion: Study in Healthy Volunteers of the Safety and Metabolism of Different Doses of the Anti-HIV Drug TMC278LA. (clinicaltrials.gov) - Aug 2, 2012
P1, N=66, Completed, Sponsor: St Stephens Aids Trust
Recruiting --> Completed Active, not recruiting --> Completed
- Trial completion, IO biomarker: Study of Bone Disease in Older HIV-infected Adults (clinicaltrials.gov) - Jul 31, 2012
P=N/A, N=101, Completed, Sponsor: Ruth M. Rothstein CORE Center
Active, not recruiting --> Completed Recruiting --> Completed
- Enrollment change: HIVERS: Renal Function Assessment in HIV Patient (clinicaltrials.gov) - Jul 29, 2012
P=N/A, N=45, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed N=60 --> 45
- Trial completion: HIVERS: Renal Function Assessment in HIV Patient (clinicaltrials.gov) - Jul 29, 2012
P=N/A, N=45, Completed, Sponsor: Assistance Publique - H
N=60 --> 45 Recruiting --> Completed
- Trial completion: Study of Pharmacokinetics in HIV-infected Women (clinicaltrials.gov) - Jul 26, 2012
P=N/A, N=88, Completed, Sponsor: Women's College Hospital
Recruiting --> Completed Recruiting --> Completed
- Trial initiation date: Assessing the Safety of Dapivirine Gel and Film Formulations (clinicaltrials.gov) - Jul 24, 2012
P1, N=60, Recruiting, Sponsor: International Partnership for Microbicides, Inc.
Recruiting --> Completed Initiation date: Apr 2012 --> Aug 2012
- || valacyclovir / Generic mfg.
Enrollment closed: Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and Shedding (clinicaltrials.gov) - Jul 24, 2012
P=N/A, N=134, Active, not recruiting, Sponsor: University of Alabama at Birmingham
Initiation date: Apr 2012 --> Aug 2012 Recruiting --> Active, not recruiting
- ||| KM023 / Kainos Medicine
Trial completion: Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023 (clinicaltrials.gov) - Jul 23, 2012
P1, N=83, Completed, Sponsor: Kainos Medicine Inc.
Recruiting --> Active, not recruiting Active, not recruiting --> Completed
- | Vocabria (cabotegravir oral) / ViiV Healthcare
New P1 trial: Relative Bioavailability Study of GSK1265744 Formulations (clinicaltrials.gov) - Jul 22, 2012
P1, N=18, Completed, Sponsor: ViiV Healthcare
- Isentress (raltegravir) / Merck (MSD)
Trial completion: CORAL: Antiretroviral Therapy Intensification With Raltegravir or Addition of Hyper-immune Bovine Colostrum in HIV-1 Infected Patients With Suboptimal CD4+ T Cell Response (clinicaltrials.gov) - Jul 22, 2012
P4, N=75, Completed, Sponsor: Kirby Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Viracept (nelfinavir) / ViiV Healthcare, Roche
Trial completion: A Study of HIV Levels During Pregnancy and After Childbirth (clinicaltrials.gov) - Jul 22, 2012
P=N/A, N=129, Completed, Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Rotarix (rotavirus vaccine) / GSK
Trial completion, Pneumococcal vaccines: Primary and Booster Vaccination Study With a Pneumococcal Vaccine in HIV Infected, HIV Exposed Uninfected and HIV Uninfected Children 6 to 10 Weeks of Age. (clinicaltrials.gov) - Jul 18, 2012
P3, N=484, Completed, Sponsor: GlaxoSmithKline
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ||||||| PREVNAR 13 (pneumococcal 13-valent conjugate vaccine) / Pfizer
Trial completion: Safety & Immunogenicity of 13vPnC in HIV-Infected Subjects Aged 18 or Older Who Were Previously Immunized With 23vPS (clinicaltrials.gov) - Jul 16, 2012
P3, N=331, Completed, Sponsor: Pfizer
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: HAART-IPT: Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons (clinicaltrials.gov) - Jul 15, 2012
P=N/A, N=1368, Completed, Sponsor: University of Cape Town
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||||||||| CIGB-300 / Center for Genetic Engineering and Biotechnology
New P2/3 trial: Recurrent and Nonrecurrent Condyloma Treatment (clinicaltrials.gov) - Jul 11, 2012
P2/3, N=132, Recruiting, Sponsor: Laboratorio Elea S.A.C.I.F. y A.
- | Trial completion: Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001) (clinicaltrials.gov) - Jul 11, 2012
P1/2, N=27, Completed, Sponsor: Thymon, LLC
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Trial completion: MSRC: Impact of Different Contraceptives on the Immune System of HIV Infected Women in Zambia (clinicaltrials.gov) - Jul 11, 2012
P2, N=66, Completed, Sponsor: University of Alabama at Birmingham
Active, not recruiting --> Completed Active, not recruiting --> Completed
- Coarsucam (artesunate/amodiaquine) / Sanofi, DNDi
Trial completion: Pharmacokinetic Interactions Between Antiretroviral Agents and Antimalarial Drug Combinations (clinicaltrials.gov) - Jul 11, 2012
P1, N=38, Completed, Sponsor: Fran Aweeka
Active, not recruiting --> Completed Recruiting --> Completed
- efavirenz / Generic mfg., artemether/lumefantrine / Generic mfg., lopinavir/ritonavir / Generic mfg.
Trial completion: Drug Interaction Study Between Antimalarial and Anti-HIV Medications (clinicaltrials.gov) - Jul 11, 2012
P1, N=33, Completed, Sponsor: University of California, San Francisco
Recruiting --> Completed Recruiting --> Completed
- Trial completion, Adherence: MAPS: Managed Problem Solving to Increase Treatment Adherence in Individuals With HIV (clinicaltrials.gov) - Jul 11, 2012
P=N/A, N=180, Completed, Sponsor: University of Pennsylvania
Recruiting --> Completed Recruiting --> Completed
- | Invirase (saquinavir) / Roche
New P1 trial: A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Na (clinicaltrials.gov) - Jul 10, 2012
P1, N=23, Completed, Sponsor: Hoffmann-La Roche
- Selzentry (maraviroc) / ViiV Healthcare
Enrollment closed: Effect of Maraviroc on Endothelial Function in HIV-Infected Patients (clinicaltrials.gov) - Jul 8, 2012
P3, N=50, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Completed Recruiting --> Active, not recruiting
- Isentress (raltegravir) / Merck (MSD)
Enrollment closed: Effect of Raltegravir on Endothelial Function in HIV-Infected Patients (clinicaltrials.gov) - Jul 8, 2012
P=N/A, N=50, Active, not recruiting, Sponsor: University of California, San Francisco
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment open: LINC: Linking Infectious and Narcology Care in Russia (clinicaltrials.gov) - Jul 2, 2012
P=N/A, N=350, Recruiting, Sponsor: Boston Medical Center
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- Trial completion: Motiv82Change: an HIV Prevention Study for Young Latino Men (clinicaltrials.gov) - Jun 27, 2012
P=N/A, N=200, Completed, Sponsor: Nova Southeastern University
Not yet recruiting --> Recruiting Recruiting --> Completed
- rosiglitazone / Generic mfg.
Trial completion: Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance (clinicaltrials.gov) - Jun 27, 2012
P1/2, N=77, Completed, Sponsor: Weill Medical College of Cornell University
Recruiting --> Completed Active, not recruiting --> Completed
- AVX101 / AlphaVax
Enrollment change: Safety of an HIV Vaccine (AVX101) in HIV Uninfected Volunteers in the United States and South Africa (clinicaltrials.gov) - Jun 26, 2012
P1, N=48, Completed, Sponsor: AlphaVax, Inc.
Active, not recruiting --> Completed N=96 --> 48
- | Enrollment closed: Vitamin D Supplementation in HIV (clinicaltrials.gov) - Jun 26, 2012
P2/3, N=58, Active, not recruiting, Sponsor: Children's Hospital of Philadelphia
N=96 --> 48 Recruiting --> Active, not recruiting
- Clinical: imPACT: Evaluation of Behavioral Intervention for HIV Positive Prisoners in NC and TX (clinicaltrials.gov) - Jun 25, 2012
P=N/A, N=400, Recruiting, Sponsor: University of North Carolina, Chapel Hill
- | Tivicay (dolutegravir) / ViiV Healthcare
Enrollment closed, Combination therapy: A Study of the Pharmacokinetics and Antiviral Activity of Dolutegravir in the Central Nervous System in HIV-1 Infected ART-naive Subjects (clinicaltrials.gov) - Jun 25, 2012
P3, N=13, Active, not recruiting, Sponsor: ViiV Healthcare
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- Enrollment change: Cardiovascular Risk Factor Management in HIV Infection (clinicaltrials.gov) - Jun 24, 2012
P4, N=4097, Completed, Sponsor: University Hospital, Basel, Switzerland
Recruiting --> Active, not recruiting N=816 --> 4097
- ||| azithromycin / Generic mfg.
Trial completion: Drug Use Investigation On Zithromac (Azithromycin) In HIV Patients (clinicaltrials.gov) - Jun 24, 2012
P=N/A, N=476, Completed, Sponsor: Pfizer
N=816 --> 4097 Enrolling by invitation --> Completed
- Trial completion: Cardiovascular Risk Factor Management in HIV Infection (clinicaltrials.gov) - Jun 24, 2012
P4, N=4097, Completed, Sponsor: University Hospital, Basel, Switzerland
Enrolling by invitation --> Completed Recruiting --> Completed